Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Published Results Confirm Regorafenib Safety, Efficacy in mCRC

Safety and efficacy findings for regorafenib in patients with previously treated metastatic colorectal cancer were consistent with previous phase III results.
Read More >>

Kopetz Highlights Emerging Regimens in Colorectal Cancer

Bekaii-Saab Shares Insight on Regorafenib Updates in mCRC

Expert Discusses Finding the Optimal Treatment Strategy in CRC

Expert Highlights Latest Immunotherapy Efforts in CRC

FDA Grants Novel Triplet Breakthrough Designation in BRAF+ mCRC

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

2018 Lynn Sage Breast Cancer Symposium

Dr. McCollum on Maintenance Therapy for Metastatic CRC

Dr. Becerra Discusses Dosing Strategies in CRC

Dr. Eng Discusses the ADORE Trial in Rectal Cancer

Dr. McCollum on Molecular Testing in CRC

Dr. Becerra Discusses an Investigational Cellular Therapy in CRC

Dr. Bekaii-Saab Discusses Regorafenib Use in mCRC

Dr. McCollum on Frontline Therapy for Patients With Metastatic CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Healthy Lifestyle and Improved Survival Benefit in CRC

Adjuvant Therapy for Stage 2/3 Colorectal Cancer

Immunotherapy Combinations in MSI and MSS mCRC

$Sequencing and Dosing for Refractory Colon Cancer$

Management of Regional Colorectal Cancer Metastases

Treatment of BRAF-Mutated Metastatic Colorectal Cancer

Second-Line PFS With Combination Biologics in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Other I-O Approaches to Metastatic Colorectal Cancer

I-O Therapy in mCRC: Ipilimumab + Nivolumab

ReDOS Trial: Optimizing Regorafenib Dosing in metastatic Colorectal Cancer

Later Lines of Therapy for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer: Multiple Lines of Therapy

Next-Generation Sequencing and Molecular Subsets in Metastatic Colorectal Cancer

The Current Paradigm of Metastatic Colorectal Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals of HPV Vaccine and NGS Assay, Priority Review in Myeloma, and More